As reported [19, 20], we found that treatment with AngII (1.44 mg/kg/day) for 28 consecutive days promotes AAA formation in Apoe−/− mice as evidenced by enlarged abdominal aortas morphologically (Figure 1A). The gene discussed is APOE; the disease is triple-A syndrome.